Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Clinical trial NCT04906083 · UNKNOWN

Trial details

NCT number: NCT04906083
Sponsor: Tongji Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Liver Failure Thrombocytopenia Decompensated Cirrhosis

Start date: 2021-02-01
Primary completion: 2022-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.